Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Massive obstetric haemorrhage.

J Bonnar1

  • 1Trinity College, University of Dublin, Ireland.

Bailliere'S Best Practice & Research. Clinical Obstetrics & Gynaecology
|May 2, 2000
PubMed
Summary
This summary is machine-generated.

Massive obstetric haemorrhage is a leading cause of maternal death. Prompt management of hypovolaemia, coagulation defects, and bleeding control are crucial for preventing avoidable deaths.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An unusual presentation of a renal adenocarcinoma.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2018
Same author

Prevention and treatment of venous thromboembolism--International Consensus Statement.

International angiology : a journal of the International Union of Angiology·2014
Same author

Transfusion of blood components to infants under four months: review and guidelines.

Irish medical journal·2007
Same author

The use of intrapartum electronic fetal heart rate monitoring: a national survey.

Irish medical journal·2007
Same author

Potential predictors of chemotherapy response in ovarian cancer--how do we define chemosensitivity?

Gynecologic oncology·2006
Same author

Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy.

Maturitas·2002
Same journal

Angiogenesis and intrauterine growth restriction.

Bailliere's best practice & research. Clinical obstetrics & gynaecology·2001
Same journal

Angiogenesis and placental growth in normal and compromised pregnancies.

Bailliere's best practice & research. Clinical obstetrics & gynaecology·2001
Same journal

Placental vascular morphogenesis.

Bailliere's best practice & research. Clinical obstetrics & gynaecology·2001
Same journal

Clinical implications of disturbances of uterine vascular morphology and function.

Bailliere's best practice & research. Clinical obstetrics & gynaecology·2001
Same journal

Endometrial angiogenesis.

Bailliere's best practice & research. Clinical obstetrics & gynaecology·2001
Same journal

Angiogenesis in ovarian cancer.

Bailliere's best practice & research. Clinical obstetrics & gynaecology·2001
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Maternal Health
  • Hemorrhagic Management

Background:

  • Massive obstetric haemorrhage (MOH) is a significant contributor to maternal mortality and morbidity.
  • Key causes include abruptio placentae, placenta praevia, and postpartum haemorrhage.
  • Avoidable factors in MOH-related maternal deaths often involve delays in managing hypovolaemia, coagulation defects, and surgical bleeding control.

Purpose of the Study:

  • To outline a protocol for managing massive obstetric haemorrhage.
  • To emphasize timely interventions for hypovolaemia, coagulation, and surgical bleeding control.
  • To discuss management strategies for rare catastrophic bleeding complications.

Main Methods:

  • The study proposes a protocol for managing MOH.

Related Experiment Videos

  • Prioritizes rapid correction of hypovolaemia using crystalloids and red blood cells.
  • Recommends blood component therapy based on laboratory tests and clinical assessment.
  • Highlights the importance of serial monitoring of treatment response.

    • Main Results:

    • Hypotension degree serves as an initial indicator of blood loss, with exceptions like abruptio placentae.
    • Uterine atony can be managed with oxytocin and prostaglandins.
    • Surgical interventions like arterial ligation or embolization are effective for traumatic bleeding.
    • Rare complications like liver rupture require multidisciplinary team management.

    Conclusions:

    • Effective management of MOH hinges on rapid resuscitation, appropriate blood component therapy, and timely surgical or medical interventions.
    • A structured protocol and multidisciplinary approach are vital for improving outcomes in severe obstetric bleeding.
    • Addressing delays in diagnosis and treatment is paramount to reducing maternal mortality from haemorrhage.